Determination of Longus Colli Muscle Thickness by Ultrasonography

September 30, 2022 updated by: Halil Cetingok, Istanbul University

How Far Should The Needle Be Withdrawn for Stellate Ganglion Block: Determination of Longus Colli Muscle Thickness by Ultrasonography

This study aims to assess the longus colli muscle thickness by ultrasonography in order to guide stellate ganglion blocks

Study Overview

Detailed Description

Stellate ganglion block is an interventional pain management procedure that is often performed for diagnostic and therapeutic purposes. It has long been performed with the guidance of fluoroscopy, and despite the increasing use of ultrasonography in recent years, fluoroscopy is still the gold standard method.

In traditional fluoroscopic method, the needle is directed to the transverse process of the C6 vertebra, after touching the anterior tubercle (Chassaignac's tubercule) the needle is slightly withdrawn and following a negative aspiration, injection is performed.

The ideal placement of the needle should be anterolateral to the longus colli muscle and deep to the prevertebral fascia. Further placement may cause intramuscular spread and superficial placement may cause injection in the carotid sheath or vascular structures. These are the most important reasons for clinical ineffectiveness. How far should the needle be withdrawn? Data is inconsistent in the literature.

The primary aim of this study is to determine the distance from transverse process to longus colli muscles anterior border and from transverse process to carotid sheath's posterior border. Secondary aim is to investigate the relationship between longus colli muscle thickness and age, gender, height, weight, BMI and neck circumference.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34093
        • Halil Çetingök

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers

Description

Inclusion Criteria:

  • Age between 18 - 65 years,
  • Giving informed consent for examination, ultrasonographic evaluation and study participation

Exclusion Criteria:

  • Having a chronic neck pain for more than 6 months,
  • Having any neurological or musculoskeletal conditions that may affect the anatomy of cervical region (cervical disc herniation, torticollis, severe scoliosis, vertebral malformation, spinal stenosis, myopathies, etc.)
  • Having a history of surgery or radiation therapy in the cervical region

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distance between corpus and longus colli muscle's anterior border on C6 level (millimeters)
Time Frame: 0 minutes
Distance between corpus and longus colli muscle's anterior border on C6 level will be evaluated with ultrasonography.
0 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distance between corpus and longus colli muscle's anterior border on C7 level (millimeters)
Time Frame: 0 minutes
Distance between corpus and longus colli muscle's anterior border on C7 level will be evaluated with ultrasonography.
0 minutes
Maximum anteroposterior width of longus colli muscle on C6 level (millimeters)
Time Frame: 0 minutes
Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.
0 minutes
Maximum anteroposterior width of longus colli muscle on C7 level (millimeters)
Time Frame: 0 minutes
Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography.
0 minutes
Distance between esophagus and estimated needle plane (millimeters)
Time Frame: 0 minutes
Distance between esophagus and estimated needle plane will be evaluated with ultrasonography.
0 minutes
Neck circumference (centimeters)
Time Frame: 0 minutes
Neck circumference
0 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Halil Çetingök, Ass. Prof., Istanbul University Istanbul Faculty of Medicine, Department of Pain Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

March 1, 2022

Study Completion (Actual)

June 1, 2022

Study Registration Dates

First Submitted

September 28, 2021

First Submitted That Met QC Criteria

October 24, 2021

First Posted (Actual)

November 4, 2021

Study Record Updates

Last Update Posted (Actual)

October 3, 2022

Last Update Submitted That Met QC Criteria

September 30, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe